AIMS: The primary objective was to assess the occurrence rate of Medication-Related OsteoNecrosis of the Jaw (MRONJ) after dental extraction in patients treated with Anti-Resorptive Drugs (ARD) for OsteoPorosis (OP) or for oncological reasons. The secondary objective was to compare the extraction techniques regarding the occurrence of MRONJ. MATERIALS AND METHODS: A systematic search in PubMed/MEDLINE, EMBASE and LILACS databases was performed. Prospective studies considering human patients treated with ARD and providing information regarding the occurrence of MRONJ after dental extraction were selected. Meta-analysis for incidence of MRONJ at the patient level was performed. The effect of administration route and surgical technique on M...
Introduction The use of antiresorptive drugs concerns many medical specialties either in relation to...
ObjectiveThe aim of this study was to investigate the relationship between type of antiresorptive me...
Introduction. The present retrospective chart review registered Medication-Related Osteonecrosis of ...
Objectives: Medication-related osteonecrosis of the jaws (MRONJ) is a serious condition whose risk f...
Abstract Tooth extraction has been avoided since it has been considered a major risk factor for medi...
Purpose: Tooth and root extractions represent trigger factors for medication-related osteonecrosis o...
Background: Medication-related osteonecrosis of the jaws (MRONJ) is a mucosal lesion of the maxillof...
Methods for preventing medication-related osteonecrosis of the jaw (MRONJ) in cancer patients who ha...
Medication-related osteonecrosis of the jaw is a recent pathology, initially mentioned in 2003 by Ma...
BACKGROUND AND AIMS:Little is currently known about the risk of developing bisphosphonate-related os...
Medication-related osteonecrosis of the jaws (MRONJ) has multiple exogenous and endogenous risk fact...
A retrospective analysis was performed with the aim of understanding whether the risk factors showed...
Background: Medication-related osteonecrosis of the jaw (MRONJ) is a well-known severe adverse react...
Bisphosphonates toxicological effect on alveolar bone could be associated to medication related oste...
Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) is a dreaded complication in patients ...
Introduction The use of antiresorptive drugs concerns many medical specialties either in relation to...
ObjectiveThe aim of this study was to investigate the relationship between type of antiresorptive me...
Introduction. The present retrospective chart review registered Medication-Related Osteonecrosis of ...
Objectives: Medication-related osteonecrosis of the jaws (MRONJ) is a serious condition whose risk f...
Abstract Tooth extraction has been avoided since it has been considered a major risk factor for medi...
Purpose: Tooth and root extractions represent trigger factors for medication-related osteonecrosis o...
Background: Medication-related osteonecrosis of the jaws (MRONJ) is a mucosal lesion of the maxillof...
Methods for preventing medication-related osteonecrosis of the jaw (MRONJ) in cancer patients who ha...
Medication-related osteonecrosis of the jaw is a recent pathology, initially mentioned in 2003 by Ma...
BACKGROUND AND AIMS:Little is currently known about the risk of developing bisphosphonate-related os...
Medication-related osteonecrosis of the jaws (MRONJ) has multiple exogenous and endogenous risk fact...
A retrospective analysis was performed with the aim of understanding whether the risk factors showed...
Background: Medication-related osteonecrosis of the jaw (MRONJ) is a well-known severe adverse react...
Bisphosphonates toxicological effect on alveolar bone could be associated to medication related oste...
Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) is a dreaded complication in patients ...
Introduction The use of antiresorptive drugs concerns many medical specialties either in relation to...
ObjectiveThe aim of this study was to investigate the relationship between type of antiresorptive me...
Introduction. The present retrospective chart review registered Medication-Related Osteonecrosis of ...